Search research articles
Contact Us
Filters
Showing results (621-630 of 836) with videos related to
Page
of 84
Sort By:
Intestinal Research
|
August 28, 2023
Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
Sung Wook Hwang, Min Kyu Kim, Mi-Na Kweon
Intestinal Research
|
April 20, 2026
One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study
Ji Eun Baek, Min Kyu Kim, Eun Soo Kim, et al.
Intestinal Research
|
April 20, 2026
Impact of Portulaca oleracea L. extract in patients with irritable bowel syndrome
Kwangwoo Nam, Jung Ho Choi, Yong Sung Kim, et al.
Intestinal Research
|
June 1, 2026
Rapid diagnosis and therapeutic mitigation in inflammatory bowel disease: utilizing the window of opportunity-findings from the UAE Epi-IBD study
Thaer Khaleel Swaid, Layth Raafat Hamzeh, Laurette L Bukasa, et al.
Intestinal Research
|
May 19, 2026
Comments on "Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan"
Chenchen Xu, Hailing Li
Intestinal Research
|
May 19, 2026
Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study"
Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda
Intestinal Research
|
May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease
Hsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Intestinal Research
|
May 7, 2026
Dyslipidemia and hyperglycemia synergistically increase the risk of intestinal barrier dysfunction: evidence from a case-control study in China
Chao Zhang, Dandan Lin, He Yu, et al.
Intestinal Research
|
June 4, 2025
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study
Taku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Intestinal Research
|
February 5, 2020
The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease
Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, et al.
Page
of 84
Search research articles
Search
Showing results (621-630 of 836) with videos related to
Sort By:
Page
of 84
Intestinal Research
|
August 28, 2023
Gut microbiome on immune checkpoint inhibitor therapy and consequent immune-related colitis: a review
Sung Wook Hwang, Min Kyu Kim, Mi-Na Kweon
Intestinal Research
|
April 20, 2026
One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study
Ji Eun Baek, Min Kyu Kim, Eun Soo Kim, et al.
Intestinal Research
|
April 20, 2026
Impact of Portulaca oleracea L. extract in patients with irritable bowel syndrome
Kwangwoo Nam, Jung Ho Choi, Yong Sung Kim, et al.
Intestinal Research
|
June 1, 2026
Rapid diagnosis and therapeutic mitigation in inflammatory bowel disease: utilizing the window of opportunity-findings from the UAE Epi-IBD study
Thaer Khaleel Swaid, Layth Raafat Hamzeh, Laurette L Bukasa, et al.
Intestinal Research
|
May 19, 2026
Comments on "Efficacy and safety of mirikizumab in maintenance therapy for ulcerative colitis in difficultto- treat inflammatory bowel disease: a single-center retrospective study in Japan"
Chenchen Xu, Hailing Li
Intestinal Research
|
May 19, 2026
Comments on "Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study"
Joaquín Borrás-Blasco, Alejandro Valcuende-Rosique, Silvia Cornejo-Uixeda
Intestinal Research
|
May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel disease
Hsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Intestinal Research
|
May 7, 2026
Dyslipidemia and hyperglycemia synergistically increase the risk of intestinal barrier dysfunction: evidence from a case-control study in China
Chao Zhang, Dandan Lin, He Yu, et al.
Intestinal Research
|
June 4, 2025
The duration of prior anti-tumor necrosis factor agents is associated with the effectiveness of vedolizumab in patients with ulcerative colitis: a real-world multicenter retrospective study
Taku Kobayashi, Tadakazu Hisamatsu, Satoshi Motoya, et al.
Intestinal Research
|
February 5, 2020
The prevalence of sarcopenia and its effect on prognosis in patients with Crohn's disease
Chan Hyung Lee, Hyuk Yoon, Dong Jun Oh, et al.
Page
of 84